Merus Nv share price logo

Merus Nv Share Price

NASDAQ: MRUS

$90.00

-6.92

(-7.14%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 29 Dec 2025

Merus Nv Stock Performance

as on December 30, 2025 at 7:59 am IST

  • Day's Low

    Day's High

    $87.14
    $96.86
    downward going graph

    3.18%

    Downside

    7.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $33.19
    $97.14
    downward going graph

    63.12%

    Downside

    7.93%

    Upside

    downward going graph

Merus Nv share price movements today

Previous Close
$96.92
Open
$96.86
Volume
3.3M
Day's Low - High
$87.14 - $96.86
52 Week Low - High
$33.19 - $97.14

Merus Nv Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Merus Nv Stock Fundamentals & Key Indicators

Check Merus Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Merus Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Merus Nv with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Merus Nv image
Merus Nv
BUY$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$31.3B350.12%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.1B134.86%136.798.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$110.0B103.33%28.2532.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$78.0B56.74%17.7931.41%

Analyst Recommendation on Merus Nv Stock

Based on 20 analysts

BUY

95.00%

Buy

5.00%

Hold

0.00%

Sell

Based on 20 analysts, 95% of analysts recommend a 'BUY' rating for Merus Nv. Average target price of $97

Merus Nv Share Price Target

Get share price movements and forecasts by analysts on Merus Nv.

What analysts predicted

7.22%UPSIDE

Target Price

$97

Current Price

$90

Analyzed by

20 Analysts

Target

$97.00

Merus Nv target price $97, a slight upside of 7.22% compared to current price of $90. According to 20 analysts rating.

Merus Nv Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
9
10
8
7
6
10
8
24
7
10
Gross Profit
-16
7
5
-28
-39
4
0
-49
-72
9
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-29
-21
-54
-31
-46
-89
-29
-89
-134
-81
Net Profit Margin
-305.78%
-208.57%
-672.93%
-436.76%
-682.52%
-848.67%
-338.33%
-364.22%
-1792.23%
-786.17%

Merus Nv Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
1
2
21
33
27
24
43
38
39
34
Gross Profit
-14
-15
-12
-14
-21
-32
-43
28
29
12
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-23
-47
-64
-24
-49
-70
-58
-122
-140
-207
Net Profit Margin
-1220.79%
-1889.92%
-295.57%
-73.77%
-177.15%
-285.59%
-136.06%
-315.48%
-352.56%
-595.93%

Global Institutional Holdings in Merus Nv

Funds
Holdings
FMR Inc
9.9%
Paradigm Biocapital Advisors LP
5.66%
RTW INVESTMENTS, LLC
5.29%
Wellington Management Company LLP
4.93%
COMMODORE CAPITAL LP
4.66%
See all

Merus Nv News & Key Events

  • img

    Today's Timeline - 29 September

    Mon, 05:02 PM

    -

    Genmab expects to finalize the Merus acquisition in Q1 2026, enhancing its drug pipeline.

    Mon, 07:16 PM

    -

    Citi downgraded Merus to Neutral after Genmab's acquisition announcement, with a price target of $97.

    Mon, 07:45 PM

    -

    Genmab's acquisition of Merus valued at $97 per share, a 41% premium over previous closing price.

  • img

    Today's Timeline - 29 September

    Mon, 09:18 PM

    -

    Merus shares surged 36% after Genmab agreed to acquire the company for $8 billion, or $97 per share.

Insights on Merus Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -134.32M → -81.55M (in $), with an average increase of 64.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 7.49M → 10.37M (in $), with an average increase of 27.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 155.4% return, outperforming this stock by 41.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 782.6% return, outperforming this stock by 300.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MRUS stock has moved down by -7.1%

About Merus Nv

Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
OrganisationMerus Nv
E-voting on sharesClick here to vote

FAQs

What is Merus Nv share price today?

Merus Nv share price today is $90 as on at the close of the market. Merus Nv share today touched a day high of $96.86 and a low of $87.14.

What is the 52 week high and 52 week low for Merus Nv share?

Merus Nv share touched a 52 week high of $97.14 on and a 52 week low of $33.19 on . Merus Nv stock price today i.e. is closed at $90,which is 7.35% down from its 52 week high and 171.17% up from its 52 week low.

How to invest in Merus Nv Stock (MRUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Merus Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Merus Nv Shares that will get you 0.0167 shares as per Merus Nv share price of $90 per share as on December 30, 2025 at 2:29 am IST.

What is the minimum amount required to buy Merus Nv Stock (MRUS) from India?

Indian investors can start investing in Merus Nv (MRUS) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Merus Nv stock (as per the Rupee-Dollar exchange rate as on ). Based on Merus Nv share’s latest price of $90 as on December 30, 2025 at 2:29 am IST, you will get 0.1111 shares of Merus Nv. Learn more about fractional shares .